Ensysce Biosciences Inc Capital Reinvestment Ratio

Latest as of March 2020: 0.00x

Ensysce Biosciences Inc capital reinvestment ratio. Ensysce Biosciences Inc (ENSC) has a Capital Reinvestment Ratio of 0.00x as of March 2020, meaning it reinvests 0% of its operating cash flow ($136.09 Million) in capital expenditures ($4.00). Check Ensysce Biosciences Inc (ENSC) total reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.

Capital Reinvestment Ratio

0.00x

Capex / Operating Cash Flow

Operating Cash Flow

$136.09 Million

USD

Capital Expenditures

$4.00

USD

Data as of

Mar 2020

Most recent filing

Capital Reinvestment Ratio of Ensysce Biosciences Inc (2019–2019)

Capital reinvestment ratio of Ensysce Biosciences Inc from 2019 to 2019. This chart tracks Ensysce Biosciences Inc's Capital Reinvestment Ratio across 1 annual periods. Also explore ENSC net assets growth trend to track the company's year-over-year net asset growth rate.

Ensysce Biosciences Inc Capital Reinvestment Ratio by Year (2019–2019)

Ensysce Biosciences Inc capital reinvestment ratio by year from 2019 to 2019. For the full cash flow conversion analysis, see cash efficiency ratio of Ensysce Biosciences Inc.

Year	Reinvestment Ratio	Operating CF (USD)	Capital Expenditures	YoY Change
2019	0.00x	$10.99 Million	$4.00	—

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow